To address whether the presence of anti-KIR autoantibodies is associated with any clinical or laboratory parameters, we reviewed the medical records, analyzed serum IFN-α levels and compared them between SLE patients harboring 0, 1, 2, 3, or >3 anti-KIR autoantibodies. This evidence concerns the gene KIR3DL1 and systemic lupus erythematosus.